Table 2.
Cardio characteristics in FD cohort. Variables are presented as mean ± STDEV or percentages ± STDEV. & A patient after heart transplantation was excluded from the study.
| No HCM | Borderline | HCM Mild | HCM Moderate/Severe |
|||||
|---|---|---|---|---|---|---|---|---|
| F (n = 7) |
M (n = 4) |
F (n = 3) |
M (n = 3) |
F (n = 11) |
M (n = 7) |
F (n = 3) |
M (n = 7) |
|
| Age | 30.7 ± 11 | 33.4 ± 14 | 54 ± 14 | 42.6 ± 15 | 43.6 ± 13 | 32 ± 12 | 50 ± 13 | 47 ± 14 |
| Age min | 18 | 18 | 39 | 27 | 22 | 21 | 40 | 24 |
| Age max | 46 | 53 | 68 | 58 | 63 | 54 | 65 | 65 |
| LVPWd | 0.7 ± 0.1 | 0.8 ± 0.05 | 0.8 ± 0.1 | 0.9 ± 0.06 | 1.08 ± 0.08 | 1.1 ± 0.05 | 1.3 ± 0.15 | 1.4 ± 0.1 |
| LV mass | 84.6 ± 16 | 116.6 ± 17 | 83 ± 4 | 120 ± 11 | 118.1 ± 29 | 173 ± 31 | 243 | 282 ± 169 |
| LVEF % | 62.3 ± 3 | 61.5 ± 2 | 56.3 ± 2 | 62.6 ± 5 | 59.3 ± 3 | 57.1 ± 5 | 54.0 ± 8 | 54 ± 3 |
| EKG | normal | normal | abnormal | abnormal | abnormal | abnormal | abnormal | abnormal |
| Fibrosis | no | No | no | no | 5 | 2 | 1 & | 5 |
Abbreviations: F—females; M—males; LVPWDd, cm—left ventricular posterior wall end diastole and end systole; LVmass, g—left ventricular mass; LV mass/BSA gm/m2—LV mass indexed to body surface area; LVEF—left ventricular ejection fraction; RVEF—right ventricular ejection fraction; LVIDd and LVIDs—left ventricular internal diameter end diastole and end systole; IVSd– interventricular septal end diastole; LVED—left ventricular end-diastolic pressure; LVEDd—left ventricular end-diastolic diameter; N/A—no data; Fibrosis—number of patients with fibrosis.